She previously served as Chief Executive Officer at Harpoon Therapeutics until the company’s acquisition by Merck in early 2024 ... scientist at the University Hospital of Dusseldorf in Germany and ...
FRANKFURT, Nov 14 (Reuters) - Merck KGaA (MRCG.DE), opens new tab on Thursday reported a gain of 11.9% in adjusted quarterly ...
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
(Bloomberg) -- Merck KGaA posted earnings that topped estimates as its ... That’s better than the €1.56 billion average of ...
In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Intel Corporation, one of the world’s largest semiconductor designers and ...
Merck KGaA (MKGAY.PK), a German science and technology major, announced that the Phase III MANEUVER trial of pimicotinib, an ...
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
Driven by growth across the board, including in its semiconductor business, German science and technology company Merck ...
The focus is on the application of Artificial Intelligence for innovations aimed at making semiconductor processes more sustainable DARMSTADT, Germany, November 07, 2024--(BUSINESS WIRE)--Merck ...